Literature DB >> 7763087

Detection of inflammatory cytokines in psoriatic skin.

Y Yoshinaga1, M Higaki, S Terajima, E Ohkubo, T Nogita, N Miyasaka, M Kawashima.   

Abstract

Recent investigations have revealed the involvement of cytokines in the pathogenesis of psoriasis. This study examined the amount of inflammatory cytokines--interleukin-1 (IL-1), interleukin-6 (IL-6) and granulocyte macrophage colony-stimulating factor (GM-CSF)--released into the supernatants of organ cultures of involved and uninvolved skin from psoriatic patients and normal skin from healthy individuals. Bioassays were employed to detect the activities of IL-1 and IL-6. Enzyme-linked immunosorbent assay (ELISA) methods were used to quantitate immunoreactive IL-1 alpha, IL-1 beta, IL-6 and GM-CSF. The activity of IL-1 in uninvolved psoriatic skin was found to be increased relative to that in involved and normal skin, while immunoreactive IL-1 beta was found only in involved skin. A neutralization experiment showed that bioactive IL-1 was mostly attributable to IL-1 alpha. Uninvolved psoriatic skin also secreted higher amounts of both bioactive and immunoreactive IL-6 compared with involved skin. Immunoreactive GM-CSF was detected in uninvolved skin only. These cytokines detected in uninvolved skin may have been released from epidermal or mesenchymal cells, since uninvolved skin contained fewer inflammatory infiltrates. Our results offer additional evidence that increased amounts of inflammatory cytokines in uninvolved skin may provide a preliminary condition and play important roles in the initial events in the evolution of psoriatic lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7763087     DOI: 10.1007/BF01262325

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  33 in total

1.  Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum.

Authors:  L C Gahring; A Buckley; R A Daynes
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

2.  Interleukin-6. The major regulator of acute-phase protein synthesis in man and rat.

Authors:  J V Castell; T Andus; D Kunz; P C Heinrich
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

3.  Interleukin-6 is produced by epidermal cells and plays an important role in the activation of human T-lymphocytes and natural killer cells.

Authors:  T A Luger; T Schwarz; J Krutmann; R Kirnbauer; P Neuner; A Köck; A Urbanski; W Borth; E Schauer
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

4.  Interleukin 1 binds to specific receptors on human keratinocytes and induces granulocyte macrophage colony-stimulating factor mRNA and protein. A potential autocrine role for interleukin 1 in epidermis.

Authors:  T S Kupper; F Lee; N Birchall; S Clark; S Dower
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

5.  Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor.

Authors:  C G Larsen; A O Anderson; J J Oppenheim; K Matsushima
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

6.  Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment.

Authors:  A Oxholm; P Oxholm; B Staberg; K Bendtzen
Journal:  Acta Derm Venereol       Date:  1989       Impact factor: 4.437

7.  A simple, sensitive bioassay for the detection of interleukin-1 using human melanoma A375 cell line.

Authors:  S Nakai; K Mizuno; M Kaneta; Y Hirai
Journal:  Biochem Biophys Res Commun       Date:  1988-08-15       Impact factor: 3.575

8.  Growth autonomy and tumorigenicity of interleukin 6-dependent B cells transfected with interleukin 6 cDNA.

Authors:  N Tohyama; H Karasuyama; T Tada
Journal:  J Exp Med       Date:  1990-02-01       Impact factor: 14.307

9.  Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells.

Authors:  P L Kilian; K L Kaffka; A S Stern; D Woehle; W R Benjamin; T M Dechiara; U Gubler; J J Farrar; S B Mizel; P T Lomedico
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

10.  Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1 alpha and beta mRNA. Keratinocyte epidermal cell-derived thymocyte-activating factor is identical to interleukin 1.

Authors:  T S Kupper; D W Ballard; A O Chua; J S McGuire; P M Flood; M C Horowitz; R Langdon; L Lightfoot; U Gubler
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more
  8 in total

1.  Defects in dermal Vγ4 γ δ T cells result in delayed wound healing in diabetic mice.

Authors:  Zhongyang Liu; Yingbin Xu; Xiaorong Zhang; Guangping Liang; Lei Chen; Julin Xie; Jinming Tang; Jingling Zhao; Bin Shu; Shaohai Qi; Jian Chen; Gaoxing Luo; Jun Wu; Weifeng He; Xusheng Liu
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

2.  Non-invasive monitoring of skin inflammation using an oxygen-sensing paint-on bandage.

Authors:  Zongxi Li; Nalu Navarro-Alvarez; Emily J Keeley; Nicholas H Nowell; Beatriz M M Goncalves; Christene A Huang; Conor L Evans
Journal:  Biomed Opt Express       Date:  2017-09-22       Impact factor: 3.732

3.  Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation.

Authors:  Yihua Cai; Xiaoyan Shen; Chuanlin Ding; Chunjian Qi; Kejia Li; Xia Li; Venkatakrishna R Jala; Huang-ge Zhang; Tian Wang; Jie Zheng; Jun Yan
Journal:  Immunity       Date:  2011-10-06       Impact factor: 31.745

4.  Pathogenic function of IL-1 beta in psoriasiform skin lesions of flaky skin (fsn/fsn) mice.

Authors:  M Schön; C Behmenburg; D Denzer; M P Schön
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

5.  Alteration of tight junction proteins is an early event in psoriasis: putative involvement of proinflammatory cytokines.

Authors:  Nina Kirschner; Claudia Poetzl; Peter von den Driesch; Ewa Wladykowski; Ingrid Moll; Martin J Behne; Johanna M Brandner
Journal:  Am J Pathol       Date:  2009-08-06       Impact factor: 4.307

6.  ILF2 Contributes to Hyperproliferation of Keratinocytes and Skin Inflammation in a KLHDC7B-DT-Dependent Manner in Psoriasis.

Authors:  Xiran Yin; Zhenxian Yang; Mingsheng Zhu; Cheng Chen; Shan Huang; Xueqing Li; Hua Zhong; He Wen; Qing Sun; Xiaojing Yu; Jianjun Yan
Journal:  Front Genet       Date:  2022-05-02       Impact factor: 4.772

7.  Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis.

Authors:  Anna Zalewska; Ewa Głowacka; Janina Wyczółkowska; Henryk Tchórzewski; Joanna Narbutt; Anna Sysa-Jedrzejowska
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

8.  Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasis.

Authors:  Mark D Singh; Vicky King; Helen Baldwin; David Burden; Anne Thorrat; Susan Holmes; Iain B McInnes; Ruairidh Nicoll; Kave Shams; Kenneth Pallas; Thomas Jamieson; Kit Ming Lee; Jose M Carballido; Antal Rot; Gerard J Graham
Journal:  Am J Pathol       Date:  2012-08-04       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.